123 related articles for article (PubMed ID: 19340717)
1. [Bacterial corneal ulcer treated with intrastromal antibiotic. Experimental model in vivo].
Stangogiannis-Druya E; Stangogiannis-Druya C; Naranjo-Tackman R; Vanzzini V; Villar-Kurí J
Arch Soc Esp Oftalmol; 2009 Mar; 84(3):123-32. PubMed ID: 19340717
[TBL] [Abstract][Full Text] [Related]
2. Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models.
Kowalski RP; Romanowski EG; Mah FS; Shanks RM; Gordon YJ
Acta Ophthalmol; 2010 Jun; 88(4):e120-5. PubMed ID: 20456251
[TBL] [Abstract][Full Text] [Related]
3. Treatment of experimental bacterial keratitis with topical trovafloxacin.
Barequet IS; Denton P; Osterhout GJ; Tuli S; O'Brien TP
Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297
[TBL] [Abstract][Full Text] [Related]
4. Comparison of ophthalmic gatifloxacin 0.3% and ciprofloxacin 0.3% in healing of corneal ulcers associated with Pseudomonas aeruginosa-induced ulcerative keratitis in rabbits.
Jensen H; Zerouala C; Carrier M; Short B
J Ocul Pharmacol Ther; 2005 Feb; 21(1):36-43. PubMed ID: 15718826
[TBL] [Abstract][Full Text] [Related]
5. Comparative study on topical and oral administration of ofloxacin for Pseudomonas corneal ulcer in rabbits.
Shiao S; Isobe Y; Hatano H; Ohno S
Ophthalmologica; 1995; 209(3):155-9. PubMed ID: 7630623
[TBL] [Abstract][Full Text] [Related]
6. Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model.
Mah FS; Romanowski EG; Kowalski RP; Yates KA; Gordon YJ
Cornea; 2007 Jun; 26(5):585-8. PubMed ID: 17525656
[TBL] [Abstract][Full Text] [Related]
7. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis.
Guzek JP; Chacko D; Kettering JD; Wessels IF; Aprecio RM
Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of tobramycin and Ocuflox in a prophylaxis model of Staphylococcus keratitis.
Dajcs JJ; Moreau JM; Stroman DW; Schlech BA; Ke TL; Thibodeaux BA; Girgis DO; Caballero AR; O'Callaghan RJ
Curr Eye Res; 2001 Jul; 23(1):60-3. PubMed ID: 11821987
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
Caballero AR; Marquart ME; O'Callaghan RJ; Thibodeaux BA; Johnston KH; Dajcs JJ
Curr Eye Res; 2006 Jan; 31(1):23-9. PubMed ID: 16421016
[TBL] [Abstract][Full Text] [Related]
10. Microbiologic, Pharmacokinetic, and Clinical Effects of Corneal Collagen Cross-Linking on Experimentally Induced Pseudomonas Keratitis in Rabbits.
Cosar CB; Kucuk M; Celik E; Gonen T; Akyar I; Serteser M; Tokat F; Ince U
Cornea; 2015 Oct; 34(10):1276-80. PubMed ID: 26226468
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.
O'Brien TP; Maguire MG; Fink NE; Alfonso E; McDonnell P
Arch Ophthalmol; 1995 Oct; 113(10):1257-65. PubMed ID: 7575256
[TBL] [Abstract][Full Text] [Related]
12. A comparison of invasive and cytotoxic Pseudomonas aeruginosa strain-induced corneal disease responses to therapeutics.
Lee EJ; Truong TN; Mendoza MN; Fleiszig SM
Curr Eye Res; 2003 Nov; 27(5):289-99. PubMed ID: 14562165
[TBL] [Abstract][Full Text] [Related]
13. Fibrin-enmeshed tobramycin liposomes: single application topical therapy of Pseudomonas keratitis.
Frucht-Perry J; Assil KK; Ziegler E; Douglas H; Brown SI; Schanzlin DJ; Weinreb RN
Cornea; 1992 Sep; 11(5):393-7. PubMed ID: 1424666
[TBL] [Abstract][Full Text] [Related]
14. Collagen shields containing tobramycin for sustained therapy (24 hours) of experimental Pseudomonas keratitis.
Clinch TE; Hobden JA; Hill JM; O'Callaghan RJ; Engel LS; Kaufmann HE
CLAO J; 1992 Oct; 18(4):245-7. PubMed ID: 1424060
[TBL] [Abstract][Full Text] [Related]
15. Bacteriologic and clinical efficacy of ofloxacin 0.3% versus ciprofloxacin 0.3% ophthalmic solutions in the treatment of patients with culture-positive bacterial keratitis.
Prajna NV; George C; Selvaraj S; Lu KL; McDonnell PJ; Srinivasan M
Cornea; 2001 Mar; 20(2):175-8. PubMed ID: 11248824
[TBL] [Abstract][Full Text] [Related]
16. Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy.
Brockman EB; Tarantino PA; Hobden JA; Hill JM; O'Callaghan RJ; Kaufman HE; Insler MS
Refract Corneal Surg; 1992; 8(1):39-43. PubMed ID: 1554638
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis.
Engel LS; Callegan MC; Hobden JA; Reidy JJ; Hill JM; O'Callaghan RJ
Curr Eye Res; 1995 Mar; 14(3):229-34. PubMed ID: 7796606
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of a topical antibiotic irrigating solution in a model of staphylococcal keratitis after lamellar keratectomy.
Rao SN; Fong Y; Kampmeier J; LaBree LD; Tanzer DJ; McDonnell PJ
Am J Ophthalmol; 2000 Jul; 130(1):20-4. PubMed ID: 11004255
[TBL] [Abstract][Full Text] [Related]
19. Comparative trial of different anti-bacterial combinations with propolis and ciprofloxacin on Pseudomonas keratitis in rabbits.
Onlen Y; Tamer C; Oksuz H; Duran N; Altug ME; Yakan S
Microbiol Res; 2007; 162(1):62-8. PubMed ID: 16904302
[TBL] [Abstract][Full Text] [Related]
20. Topical ciprofloxacin versus topical fortified antibiotics in rabbit models of Staphylococcus and Pseudomonas keratitis.
Lauffenburger MD; Cohen KL
Cornea; 1993 Nov; 12(6):517-21. PubMed ID: 8261784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
